3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
20
Melanoma
7
Sarcoma
3
Neoplasms
3
Lymphoma
3
Uveal Melanoma
2
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Melanoma, Cutaneous Malignant
1
Lung Neoplasms
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leiomyosarcoma
1
Kidney Neoplasms
1
Immunotherapy
1
Hyperthermia
1
Colonic Neoplasms
1
Breast Neoplasms
1
Advanced Melanoma
1
Interventions
Temozolomide
42
Magnetic Resonance Spectroscopy
41
Radiotherapy
22
Specimen Handling
18
Biopsy
13
X-Rays
10
Radiation
10
trametinib
8
Bevacizumab
8
Nivolumab
7
Blood Specimen Collection
7
olaparib
6
fluorodopa F 18
6
dabrafenib
6
Radiotherapy, Intensity-Modulated
6
Phantoms, Imaging
6
Nuclear Medicine Department, Hospital
6
Lomustine
6
pembrolizumab
5
abemaciclib
5
Standard of Care
5
vorasidenib
4
ulixertinib
4
larotrectinib
4
ivosidenib
4
erdafitinib
4
Surgical Procedures, Operative
4
Dianhydrogalactitol
4
Cyclophosphamide
4
Aminolevulinic Acid
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioma
×
Dacarbazine
×
1 year
×
Clear all
No trials found.